Metastatic breastcancer

Clinical trials for Metastatic breastcancer explained in plain language.

Never miss a new study

Get alerted when new Metastatic breastcancer trials appear

Sign up with your email to follow new studies for Metastatic breastcancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Can a new chemo schedule extend life with fewer side effects?

Disease control Completed

This trial tests three different schedules of the chemotherapy drug nab-paclitaxel (Abraxane) in women with HER2-negative metastatic breast cancer. The goal is to find a schedule that allows patients to stay on treatment longer, potentially improving progression-free survival, wh…

Matched conditions: METASTATIC BREASTCANCER

Phase 2 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control

Last updated Sep 04, 2026 00:00 UTC

Metastatic breastcancer

Get alerted when new Metastatic breastcancer trials appear

Can a new chemo schedule extend life with fewer side effects?